Skip to main content
Premium Trial:

Request an Annual Quote

Roche Discloses Potential $625M Price Tag for Ariosa

NEW YORK (GenomeWeb) – Roche disclosed this week that it is paying up to $625 million for non-invasive prenatal testing firm Ariosa Diagnostics.

The terms of the deal include a cash payment of $400 million and up to $225 million from a contingent consideration arrangement, Roche said in its financial report. It also disclosed that it is paying up to $121 million for informatics company Bina Technologies, which it acquired in December.

On Wednesday, Roche reported a 3 percent increase year over year in its full-year 2014 diagnostic revenues, including a 6 percent increase in its molecular diagnostics revenues. The company did not break out its next-generation sequencing sales, but said that excluding those sales, the MDx business was up 8 percent year over year in 2014. 

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.